NEUROCRINE BIOSCIENCES INC Weighted Average Number of Shares Outstanding, Diluted from Q2 2010 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Neurocrine Biosciences Inc quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2010 to Q3 2025.
  • Neurocrine Biosciences Inc Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2025 was 103M shares, a 1.73% decline year-over-year.
  • Neurocrine Biosciences Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 104M shares, a 2.67% increase from 2023.
  • Neurocrine Biosciences Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 101M shares, a 2.12% increase from 2022.
  • Neurocrine Biosciences Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 98.9M shares, a 1.02% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)

NEUROCRINE BIOSCIENCES INC Quarterly Weighted Average Number of Shares Outstanding, Diluted (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 103M -1.8M -1.73% Jul 1, 2025 Sep 30, 2025 10-Q 2025-10-28
Q2 2025 101M -2.9M -2.79% Apr 1, 2025 Jun 30, 2025 10-Q 2025-07-30
Q1 2025 103M -1.1M -1.06% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-05
Q4 2024 104M +2.7M +2.67% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-10
Q3 2024 104M +3.2M +3.17% Jul 1, 2024 Sep 30, 2024 10-Q 2025-10-28
Q2 2024 104M +3.7M +3.69% Apr 1, 2024 Jun 30, 2024 10-Q 2025-07-30
Q1 2024 104M +6.5M +6.69% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-05
Q4 2023 101M +2.1M +2.12% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-10
Q3 2023 101M +2.1M +2.12% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-30
Q2 2023 100M +4.6M +4.81% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 97.1M -500K -0.51% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-01
Q4 2022 98.9M +1M +1.02% Oct 1, 2022 Dec 31, 2022 10-K 2025-02-10
Q3 2022 99M +1.3M +1.33% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-31
Q2 2022 95.6M -2.1M -2.15% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-01
Q1 2022 97.6M -600K -0.61% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q4 2021 97.9M +700K +0.72% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-09
Q3 2021 97.7M +4.4M +4.72% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-01
Q2 2021 97.7M -500K -0.51% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 98.2M +1.2M +1.24% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 97.2M 0 0% Oct 1, 2020 Dec 31, 2020 10-K 2021-02-05
Q3 2020 93.3M -2.8M -2.91% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-01
Q2 2020 98.2M +3.4M +3.59% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-03
Q1 2020 97M +5.9M +6.48% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 97.2M +1.48M +1.54% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-05
Q3 2019 96.1M -698K -0.72% Jul 1, 2019 Sep 30, 2019 10-K 2021-02-05
Q2 2019 94.8M +4.7M +5.22% Apr 1, 2019 Jun 30, 2019 10-K 2021-02-05
Q1 2019 91.1M +1.57M +1.76% Jan 1, 2019 Mar 31, 2019 10-K 2021-02-05
Q4 2018 95.7M +3.07M +3.31% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-07
Q3 2018 96.8M +8.47M +9.59% Jul 1, 2018 Sep 30, 2018 10-K 2020-02-07
Q2 2018 90.1M +2.04M +2.31% Apr 1, 2018 Jun 30, 2018 10-K 2020-02-07
Q1 2018 89.5M +2.24M +2.57% Jan 1, 2018 Mar 31, 2018 10-K 2020-02-07
Q4 2017 92.7M Oct 1, 2017 Dec 31, 2017 10-K 2019-02-08
Q3 2017 88.3M Jul 1, 2017 Sep 30, 2017 10-K 2019-02-08
Q2 2017 88.1M Apr 1, 2017 Jun 30, 2017 10-K 2019-02-08
Q1 2017 87.3M Jan 1, 2017 Mar 31, 2017 10-K 2019-02-08
Q4 2013 67.3M -374K -0.55% Oct 1, 2013 Dec 31, 2013 10-K 2014-02-11
Q3 2013 67.2M +857K +1.29% Jul 1, 2013 Sep 30, 2013 10-K 2014-02-11
Q2 2013 66.8M +490K +0.74% Apr 1, 2013 Jun 30, 2013 10-K 2014-02-11
Q1 2013 66.6M +3.19M +5.03% Jan 1, 2013 Mar 31, 2013 10-K 2014-02-11
Q4 2012 67.7M +11.3M +19.9% Oct 1, 2012 Dec 31, 2012 10-K 2014-02-11
Q3 2012 66.3M +9.96M +17.7% Jul 1, 2012 Sep 30, 2012 10-K 2014-02-11
Q2 2012 66.3M +9.88M +17.5% Apr 1, 2012 Jun 30, 2012 10-K 2014-02-11
Q1 2012 63.4M +7.3M +13% Jan 1, 2012 Mar 31, 2012 10-K 2014-02-11
Q4 2011 56.5M Oct 1, 2011 Dec 31, 2011 10-K 2013-02-08
Q3 2011 56.4M +730K +1.31% Jul 1, 2011 Sep 30, 2011 10-K 2013-02-08
Q2 2011 56.4M +1.6M +2.91% Apr 1, 2011 Jun 30, 2011 10-K 2013-02-08
Q1 2011 56.1M Jan 1, 2011 Mar 31, 2011 10-K 2013-02-08
Q3 2010 55.6M Jul 1, 2010 Sep 30, 2010 10-Q 2011-10-31
Q2 2010 54.8M Apr 1, 2010 Jun 30, 2010 10-Q 2011-07-29

NEUROCRINE BIOSCIENCES INC Annual Weighted Average Number of Shares Outstanding, Diluted (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 104M +2.7M +2.67% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-10
2023 101M +2.1M +2.12% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-10
2022 98.9M +1M +1.02% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-10
2021 97.9M +100K +0.1% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-09
2020 97.8M +2.1M +2.19% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-09
2019 95.7M +300K +0.31% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-11
2018 95.4M +7.31M +8.3% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-05
2017 88.1M +1.38M +1.59% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-07
2016 86.7M +2.22M +2.62% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-08
2015 84.5M +9.92M +13.3% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-13
2014 74.6M +7.59M +11.3% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-14
2013 67M +43K +0.06% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-11
2012 66.9M +10.6M +18.8% Jan 1, 2012 Dec 31, 2012 10-K 2015-02-09
2011 56.3M +3.53M +6.68% Jan 1, 2011 Dec 31, 2011 10-K 2014-02-11
2010 52.8M Jan 1, 2010 Dec 31, 2010 10-K 2013-02-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.